SUPPRESSIVE EFFECT OF LORATADINE ON ALLERGEN-INDUCED HISTAMINE-RELEASE IN THE NOSE

被引:40
|
作者
ANDERSSON, M
NOLTE, H
BAUMGARTEN, C
PIPKORN, U
机构
[1] UNIV COPENHAGEN,STATE HOSP,DEPT MED,DK-1168 COPENHAGEN,DENMARK
[2] FREE UNIV BERLIN,DEPT CLIN IMMUNOL,W-1000 BERLIN 33,GERMANY
关键词
ALLERGIC RHINITIS; HISTAMINE; LAVAGE; METHACHOLINE; NONSPECIFIC REACTIVITY;
D O I
10.1111/j.1398-9995.1991.tb00618.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
It has been speculated whether the recently developed non-sedating antihistamines may possess other properties than merely being antagonists at the H-1-receptors. To investigate this suggestion 12 patients with strictly seasonal allergic rhinitis participated in a double-blind placebo controlled randomized cross-over study outside the pollen season. At steady state levels of 10 mg loratadine, a new non-sedating antihistamine, the patients were challenged with methacholine. This as followed by a nasal challenge with increasing doses of allergen. 24 h later the patients were rechallenged nasally with the same methacholine dose as the day before. The volume of the methacholine-induced nasal secretion was measured and the response to allergen was determined by scoring technique. In returned nasal lavage fluid the levels of histamine and TAME-esterase activity were measured. It was found that loratadine significantly reduced the immediate allergic nasal symptoms compared with placebo (P < 0.01). Loratadine also reduced the allergen-induced release of histamine into the nasal cavity after the strongest allergen dose, from 9.6 +/- 1.5 (mean +/- SEM) to 6.4 +/- 1.4 ng/ml (P < 0.05). A similar decrease in the TAME-esterase activity after treatment with loratadine was observed. The TAME-esterase activity decreased from 11.6 * 10(3) +/- 2.47 *10(3) to 5.60 *10(3) +/- 1.45 *10(3) CMP (P < 0.05). There were no significant changes between the active and placebo treatments regarding the methacholine-induced secretory response. This was true for the initial methacholine challenge as well as the secretory response 24 h later. This study shows that loratadine is an effective drug in the suppression of immediate allergic nasal symptoms. One of the beneficial effects of this drug could be a reduction in allergen-induced histamine release. A finding which further implicates that antihistamines may possess other effects than just a blocking of the H-1-receptor.
引用
收藏
页码:540 / 546
页数:7
相关论文
共 50 条
  • [21] Histamine (His) challenge of the nose and sinus: Effect of loratadine
    Baroody, FM
    Gungor, A
    DeTineo, M
    Haney, L
    Blair, C
    Naclerio, RM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S46 - S46
  • [22] HISTAMINE-RELEASE WITH A SOLID-PHASE-COUPLED ALLERGEN
    MITA, H
    TADOKORO, K
    YASUEDA, H
    SHIDA, T
    CLINICA CHIMICA ACTA, 1990, 191 (03) : 161 - 168
  • [23] NASAL HISTAMINE-RELEASE FOLLOWING HYPEROSMOLAR AND ALLERGEN CHALLENGE
    KRAYENBUHL, MC
    HUDSPITH, BN
    BROSTOFF, J
    SCADDING, GK
    GUESDON, JL
    LATCHMAN, Y
    ALLERGY, 1989, 44 (01) : 25 - 29
  • [24] INHIBITORY EFFECT OF THE H-1 ANTAGONIST LORATADINE ON HISTAMINE-RELEASE FROM HUMAN BASOPHILS
    MIADONNA, A
    MILAZZO, N
    LORINI, M
    MARCHESI, E
    TEDESCHI, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 105 (01) : 12 - 17
  • [25] EFFECT OF PHOSPHOLIPIDS ON HISTAMINE-RELEASE
    MONGAR, JL
    SVEC, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (02) : P327 - &
  • [26] Allergen-induced mediator release tests
    Demoly, P
    Lebel, B
    Arnoux, B
    ALLERGY, 2003, 58 (07) : 553 - 558
  • [27] EFFECTS OF LORATADINE ON ANTI-IGE-INDUCED INFLAMMATION, HISTAMINE-RELEASE, AND LEUKOCYTE RECRUITMENT IN SKIN OF ATOPICS
    ROQUET, A
    RAUD, J
    HALLDEN, G
    VANHAGEHAMSTEN, M
    HED, J
    HANSSON, LO
    ZETTERSTROM, O
    GRONNEBERG, R
    ALLERGY, 1995, 50 (05) : 414 - 420
  • [28] Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma
    Wang, JY
    Shieh, CC
    You, PF
    Lei, HY
    Reid, KBM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) : 510 - 518
  • [29] Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release
    Kowal, K
    Nolte, H
    Skov, PS
    DuBuske, LM
    ALLERGY AND ASTHMA PROCEEDINGS, 2005, 26 (06) : 456 - 462
  • [30] Targeted inhibition of allergen-induced histamine production by neutrophils
    Chacon, Pedro
    Vega-Rioja, Antonio
    Doukkali, Bouchra
    del Valle Rodriguez, Alberto
    Bellido, Virginia
    Puente, Yolanda
    Alcaniz, Lorena
    Rodriguez, David
    Palacios, Ricardo
    Antonio Cornejo-Garcia, Jose
    Monteseirin, Javier
    Rivas-Perez, David
    FASEB JOURNAL, 2021, 35 (05):